Outcomes of hypertrophic cardiomyopathy in Japanese children: a retrospective cohort study

Hiroki Mori1, Tadahiro Yoshikawa2, Hitomi Kimura2

  • 1Department of Pediatric Cardiology, Tokyo Women's Medical University, Tokyo, Japan.

Heart and Vessels
|November 20, 2021
PubMed

Insights

Pediatric hypertrophic cardiomyopathy (HCM) in Japan has a good long-term survival rate, with 80% of patients surviving 20 years. Heart failure symptoms and cardiothoracic ratio predict heart failure-related death in pediatric HCM.

Area of Science:

  • Cardiology
  • Pediatric Medicine
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
  • Pediatric HCM prognosis data is limited, especially from multicenter studies in Japan.

Purpose of the Study:

  • To evaluate the long-term survival rate and identify risk factors for pediatric hypertrophic cardiomyopathy (HCM) in Japan.
  • To provide crucial data for managing pediatric HCM patients.

Main Methods:

  • Retrospective multicenter observational study.
  • Involved 20 institutions and 180 patients diagnosed with HCM under 18 years old (1990-2014).
  • Analyzed survival rates, causes of death, and risk factors.

Main Results:

  • Long-term survival rates at 1, 5, 10, and 20 years were 97%, 92%, 84%, and 80%, respectively.
  • 26 deaths occurred: 11 sudden (arrhythmia) and 15 heart failure-related.
  • Heart failure symptoms and higher cardiothoracic ratio were significant risk factors for heart failure-related death.

Conclusions:

  • The prognosis for pediatric hypertrophic cardiomyopathy in Japan is favorable and comparable to international studies.
  • Identified key risk factors for heart failure-related mortality in this population.
  • Further research is needed to identify risk factors for arrhythmia-related death.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
93
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
64
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
99
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
63
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
114
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
122